Skip to main content
    K

    Klotho Neurosciences, Inc. (KLTO)

    Official site

    BIOTECHNOLOGY

    $0.52
    +0.00 (+0.00%)

    Last updated: Jul 08, 2026 at 5:00 PM ET

    Klotho Neurosciences, Inc. (KLTO) Financials: Revenue, Profit and Cash Flow

    Updated Sep 30, 2026. Financial statements from company filings, amounts in US dollars.

    Klotho Neurosciences reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was -$10.55M and operating cash flow was -$5.89M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$13.64M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $7.15M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0N/AN/AN/AN/A
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020N/AN/AN/AN/AN/A
    Annual, fiscal years ended Dec 2020 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Research and development$634.19K$0$0$0$0$0
    Operating income-$7.15M-$5.54M-$631.32K-$657.02K-$1.11M-$913.15K
    Net income-$10.55M-$6.15M-$707.46K$1.23M-$1.11M-$913
    EBITDAN/AN/A-$631.24K-$101.10K-$1.11MN/A
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating income-$12.41M-$5.49M-$9.51M-$1.81M-$1.85M-$1.89M-$1.59M-$1.60M-$2.87M-$395.61K-$672.04K$62.42K
    Net income-$13.64M-$3.69M-$13.86M-$1.45M-$2.90M-$4.09M-$2.12M-$2.07M-$2.96M-$451.64K-$672.04K-$1.42M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents of $7.18M were 74.9% of total assets of $9.59M, against total liabilities of $129.76K.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Total assets$9.59M$2.46M$2.19M$118.25M$4.95K$1.07M
    Current assets$7.29M$157.81K$6.65K$440.16K$4.95K$334.87K
    Cash and equivalents$7.18M$63.74K$2.81K$340.96K$4.95K$334.87K
    Total liabilities$129.76K$1.27M$1.62M$4.93M$8.51KN/A
    Short-term debtN/A$240.75K$1.63M$1.35MN/AN/A
    Shareholder equity$9.46M$1.19M$571.72K-$4.04M-$3.56KN/A
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$137.69M$65.01M$59.74M$9.59M$10.07M$10.85M$2.99M$2.46M$2.46M$3.31M$19.59M$2.19M
    Total liabilities$1.35M$7.11M$8.27M$129.76K$145.89K$195.41K$2.35M$1.27M$1.00M$4.86M$8.50M$1.62M
    Cash and equivalents$57.39M$9.34M$10.00M$7.18M$7.35M$8.43M$565.87K$63.74K$50.90K$845.34K$8.05K$2.81K
    Shareholder equity$136.35M$57.90M$51.47M$9.46M$9.93M$10.65M$638.71K$1.19M$1.46M-$1.55M-$7.73M$571.72K
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Operating cash flow-$5.89M-$2.95M-$446.92K-$493.04K-$284.02K-$165.13K
    Capital expendituresN/A$123.50K$13.89K$125.41K$0$0
    Free cash flowN/A-$3.07M-$460.80K-$618.45K-$284.02K-$165.13K
    Dividends paid$0$120.00KN/AN/AN/AN/A
    Investing cash flow$0-$123.50K$23.85K-$116.15MN/AN/A
    Financing cash flow$13.00M$3.13M$350.00K$116.98M$250.00K$500.00K
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$10.41M-$6.85M-$4.97M-$1.28M-$1.12M-$1.94M-$1.55M-$944.15K-$1.07M-$907.42K-$21.98K-$199.51K
    Capital expenditures$20.61MN/AN/AN/A$0$1$0$4$0$3$123.50K$0
    Free cash flow-$31.01MN/AN/AN/A-$1.12M-$1.94M-$1.55M-$944.16K-$1.07M-$907.43K-$145.47K-$199.51K
    Last 12 quarters

    Frequently Asked Questions About KLTO

    What is Klotho Neurosciences' annual revenue?

    Klotho Neurosciences reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    Is Klotho Neurosciences profitable?

    No. Klotho Neurosciences reported net income of -$10.55M for the fiscal year ended Dec 31, 2025.

    How much debt does Klotho Neurosciences have?

    The balance sheet dated Dec 31, 2025 reported cash and equivalents of $7.18M.